October 20, 2022 C-Path’s Ramona Walls Promoted to Executive Director of Data Science TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) has named Ramona L. Walls, Ph.D., as Executive Director of Da
October 19, 2022-October 23, 2022 2022 IDWeek, Washington D.C Dates: October 19-23, 2022 Sessions run daily Oct. 19-23 with the closing plenary ending at 11 a.m. on Sunday, Oct. 23. IDWeek is
October 18, 2022 View Now | INC 2022 Scientific Meeting We’re excited to see you at the International Neonatal Consortium 2022 Scientific Meeting this fall. #INC2022 will feature
October 13, 2022-October 14, 2022 DIA 2022 Digital Technology in Clinical Trials Conference Early bird rates in effect until August 18! C-Path’s eCOA Consortium is co-sponsoring the DIA 2022 Digital Technology in Clini
October 13, 2022 C-Path’s Transplant Therapeutics Consortium Receives EMA Draft Qualification Opinion for iBox Scoring System The draft EMA qualification opinion is available for public consultation until November 17, 2022 Secondary endpoint prognostic for
October 6, 2022 C-Path to Lead Pre-Consortium Aimed at Transforming, Accelerating Medical Product Development in Alpha-1 Antitrypsin Deficiency TUCSON, Ariz., Oct. 6, 2022 — Critical Path Institute (C-Path) today announced that it has recently launched a pre-consortium co
October 1, 2022 Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease Autosomal recessive polycystic kidney disease (ARPKD) is a rare hepatorenal fibrocystic disease that often presents prenatally
October 1, 2022 Perspectives on Drug Development in Early ADPKD The Critical Path Institute’s Polycystic Disease Outcomes Consortium, including key stakeholders (patients, medical experts
September 29, 2022 eCOA Consortium Announces New Article for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Evaluating the Use of Backup Solutions for ePRO Systems” has been publ